Hospitals Omnicell Pharmaceutical Companies 
Omnicell
JANUARY 10, 2023
Jeff Spencer Senior Director, 340B Sales and Account Management, Omnicell Since its inception 30 years ago, the 340B Drug Pricing Program has helped non-profit healthcare organizations expand services for their communities. Hospitals and clinics are eligible based on defined criteria. So, how does 340B ESP work?
Omnicell
JANUARY 10, 2023
Interestingly, the 340B law was actually included in a veterans healthcare bill (the Veterans Health Care Act) that also established a separate drug pricing program for veterans hospitals. It also raised the DSH payment cap for some rural and small urban hospitals to 12%. 2006: Congress passed, and President George W.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omnicell
SEPTEMBER 5, 2022
Ken Perez Vice President of Healthcare Policy, Omnicell; In Sept. The 340B Drug Pricing Program enables safety-net providers—select hospitals, clinics, and health centers that serve a disproportionate share of poor patients in these urban and rural areas—to buy prescription drugs at discounted prices. 2020, the U.S.
Omnicell
FEBRUARY 13, 2023
Last month, a federal appeals court in Philadelphia sided largely with pharmaceutical companies in the ongoing showdown involving access to 340B discount pricing via contract pharmacies. What does the ruling mean for your hospital pharmacy program? The three-judge panel for the U.S.
Omnicell
MARCH 27, 2023
Ted Slafsky Founder and Principal of Wexford Solutions, Publisher, 340B Report In the past 18 months, the 340B contract pharmacy program has seemingly fractured into 17 programs, one governed by the federal government and 16 others with their own standards determined by pharmaceutical manufacturers.
Omnicell
JANUARY 10, 2023
Ken Perez Vice President of Healthcare Policy and Government Affairs, Omnicell In August, H.R. Hospitals and health systems have long advocated for lower prescription drug prices. However, the hospital association stopped short of advocating for Medicare negotiation of prescription prices. ” Sen. John Barrasso (R-Wyo.)
Omnicell
JANUARY 10, 2023
Although hospital groups were not successful in their motion to intervene in the lawsuit between AstraZeneca and U.S. Hospital groups are calling on Secretary Becerra to impose civil monetary penalties for each instance of overcharges and to require that the pharmaceutical manufacturers refund covered entities for overpayments.
Expert insights. Personalized for you.
52 
Let's personalize your content